Know Cancer

or
forgot password

Prospective Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy


N/A
20 Years
N/A
Open (Enrolling)
Both
Lung Adenocarcinoma

Thank you

Trial Information

Prospective Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy


Inclusion Criteria:



- A. Clinically and radiologically suspected lung adenocarcinoma

- B. Newly-diagnosed Stage I or II from the clinical work up including PET/CT

- C. Performance status of 0 to 1 on the ECOG scale

- D. Age 20 years or older

- E. Able to tolerable DECT imaging required by protocol

- F. Able to give study-specific informed consent

Exclusion Criteria:

- A. Prior malignancy

- B. planning of Definitive RTx 나 neoadjuvant CCRTx

- C. Poor cardiopulmonary reserve

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

Prediction of tumor aggressiveness

Outcome Time Frame:

five years

Safety Issue:

Yes

Principal Investigator

Young Mog Shim, Dr.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Samsung Medical Center

Authority:

South Korea: Institutional Review Board

Study ID:

SMC 2011-09-083

NCT ID:

NCT01482585

Start Date:

October 2011

Completion Date:

December 2016

Related Keywords:

  • Lung Adenocarcinoma
  • lung adenocarcinoma
  • prognosis
  • tumor aggressiveness
  • imaging biomarker
  • genetic biomarker
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous
  • Lung Neoplasms

Name

Location